Image

Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Immunobridging to Adults 18-49

Testing VAX-31 vaccine in adults 50+ and comparing to 18-49.

Recruiting
18 years and older
All
Phase 3

This study is testing a new vaccine called **VAX-31**. The goal is to see if it is safe, easy to handle (tolerable), and how well it works in people 50 years and older. The study also compares VAX-31 to other vaccines, **PCV21** and **PCV20**, which are approved for use. **PCV** stands for pneumococcal conjugate vaccine, which protects against diseases caused by pneumococcal bacteria, like pneumonia. People aged 18 and older can join this study if they're healthy or have stable health conditions. Before joining, participants must agree to several requirements, like giving blood samples and using a mobile device to fill out an electronic diary (eDiary). They should not have had certain vaccines recently or have medical conditions like a bleeding disorder or an infection like HIV. Pregnant or breastfeeding women cannot participate.

  • The study requires regular follow-ups and diary entries.
  • You need to be in good health or have stable health conditions.
  • Some people, like those with certain infections, cannot join.
Study details
    Pneumococcal Vaccines

NCT07284654

Vaxcyte, Inc.

28 March 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.